Results 241 to 250 of about 70,099 (277)
Some of the next articles are maybe not open access.

Osteonecrosis

JBJS Journal of Orthopaedics for Physician Assistants, 2022
Osteonecrosis has become the standardized term for a condition of many and varied etiologies. In this brief review, we note the evolution of the standardization of the condition and we also delve into the intraosseous versus extraosseous etiologies. Additionally, we list some of the more common medications known to cause osteonecrosis.
Maria Lawhorne, Ricky Kortyna
  +4 more sources

Osteonecrosis

Best Practice & Research Clinical Rheumatology, 2000
Osteonecrosis (avascular necrosis, aseptic necrosis or subchondral avascular necrosis) is not a specific disease entity but the final common pathway of a number of conditions leading to bone death. The main predisposing factors (trauma, glucocorticosteroids, alcoholism and connective tissue disorders) should be carefully sought, but osteonecrosis can ...
  +5 more sources

Postmeniscectomy osteonecrosis

Arthroscopy: The Journal of Arthroscopic & Related Surgery, 2002
In the last few years, postmeniscectomy osteonecrosis has been reported, especially in elderly patients, with low incidence, unclear physiopathology, and without long periods of follow-up. We report a case diagnosed and followed-up for a 3-year period using magnetic resonance imaging.
Carlo, Faletti   +2 more
openaire   +2 more sources

Osteonecrosis

2012
Abstract Bisphosphonates (BPs) are a widely used class of drugs with known ef fi cacy in the prevention and treatment of postmenopausal and steroid-induced osteoporosis; Paget’s disease of bone; hypercalcemia of malignancy; osteolytic lesions of multiple myeloma; and bone metastases associated with breast, prostate, lung, and other soft tissue tumors ...
William Morrison, Javad Parvizi
  +5 more sources

Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis

Expert Opinion on Biological Therapy, 2020
Objectives: The regenerative capabilities of bone marrow-derived cell therapies (BMCTs) have been employed in combination with core decompression (CD) in the management of osteonecrosis of the femoral head to prevent or delay the necessity of total hip ...
Filippo Migliorini   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy